The shares of large drugmakers like Lilly, Gilead and J&J keep hitting record highs.
The big winners of the tech wreck are biopharma stocks
In short
Biopharma stocks have emerged as the primary beneficiaries amid a broader downturn in the technology sector. Shares of major pharmaceutical companies, including Eli Lilly, Gilead, and Johnson & Johnson, continue to reach record highs.
Key points
- Biopharma stocks have emerged as the primary beneficiaries amid a broader downturn in the…: Biopharma stocks have emerged as the primary beneficiaries amid a broader downturn in the technology sector.
- Shares of major pharmaceutical companies, including Eli Lilly, Gilead, and Johnson & John…: Shares of major pharmaceutical companies, including Eli Lilly, Gilead, and Johnson & Johnson, continue to reach record highs.